This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2006.10.068v1 49/10/1099    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Konishi, H. Articles by Cooke, J. P. Search for Related Content PubMed Articles by Konishi, H. Articles by Cooke, J. P.

PRECLINICAL STUDY

Dimethylarginine Dimethylaminohydrolase Promotes Endothelial Repair After Vascular Injury

Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California

Manuscript received July 14, 2006; revised manuscript received September 22, 2006, accepted October 9, 2006.

^_* Reprint requests and correspondence: Dr. John P. Cooke, Division of Cardiovascular Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, California 94305. (Email: john.cooke{at}stanford.edu).

Objectives: We sought to determine if a reduction in asymmetric dimethylarginine (ADMA) enhances endothelial regeneration.

Background: Asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase (NOS). Increased plasma levels of ADMA are associated with endothelial vasodilator dysfunction in patients with vascular disease or risk factors. Asymmetric dimethylarginine is eliminated largely by the action of dimethylarginine dimethylaminohydrolase (DDAH), which exists in 2 isoforms. Dimethylarginine dimethylaminohydrolase-1 transgenic (TG) mice manifest increased DDAH activity, reduced plasma and tissue ADMA levels, increased nitric oxide synthesis, and reduced systemic vascular resistance.

Methods: The left femoral arteries of DDAH1 TG mice and wild-type (WT) mice were injured by a straight spring wire, and regeneration of the endothelial cell (EC) monolayer was assessed. Endothelial sprouting was assayed with growth factor-reduced Matrigel.

Results: Regeneration of the EC monolayer was more complete 1 week after injury in TG mice (WT vs. TG: 40.0 ± 6.5% vs. 61.2 ± 6.4%, p < 0.05). The number of CD45 positive cells at the injured sites was reduced by 62% in DDAH TG mice (p < 0.05). Four weeks after injury, the neointima area and intima/media ratio were attenuated in DDAH TG mice (WT vs. TG: 0.049 ± 0.050 mm² vs. 0.031 ± 0.060 mm², 3.1 ± 0.5 vs. 1.7 ± 0.2, respectively, p < 0.05). Endothelial cell sprouting from vascular segments increased in TG mice (WT vs. TG: 24.3 ± 3.9 vs. 39.0 ± 2.2, p < 0.05).

Conclusions: We find for the first time an important role for DDAH in EC regeneration and in neointima formation. Strategies to enhance DDAH expression or activity might be useful in restoring the endothelial monolayer and in treating vascular disease.

Abbreviations and Acronyms   ADMA = asymmetric dimethylarginine   DDAH = dimethylarginine dimethylaminohydrolase   EC = endothelial cell   NO = nitric oxide   NOS = NO synthase   TG = DDAH transgenic mice   WT = wild-type mice

This article has been cited by other articles:

				L. R Fiedler, T. Bachetti, J. Leiper, I. Zachary, L. Chen, T. Renne, and B. Wojciak-Stothard The ADMA/DDAH Pathway Regulates VEGF-Mediated Angiogenesis Arterioscler Thromb Vasc Biol, December 1, 2009; 29(12): 2117 - 2124. [Abstract] [Full Text] [PDF]

				R. Maas, V. Xanthakis, J. F. Polak, E. Schwedhelm, L. M. Sullivan, R. Benndorf, F. Schulze, R. S. Vasan, P. A. Wolf, R. H. Boger, et al. Association of the Endogenous Nitric Oxide Synthase Inhibitor ADMA With Carotid Artery Intimal Media Thickness in the Framingham Heart Study Offspring Cohort Stroke, August 1, 2009; 40(8): 2715 - 2719. [Abstract] [Full Text] [PDF]

				J. G. Ayer, J. A. Harmer, S. Nakhla, W. Xuan, M. K.C. Ng, O. T. Raitakari, G. B. Marks, and D. S. Celermajer HDL-Cholesterol, Blood Pressure, and Asymmetric Dimethylarginine Are Significantly Associated With Arterial Wall Thickness in Children Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 943 - 949. [Abstract] [Full Text] [PDF]

				F. Palm, M. L. Onozato, Z. Luo, and C. S. Wilcox Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3227 - H3245. [Abstract] [Full Text] [PDF]

				A. J. Pope, L. Druhan, J. E. Guzman, S. P. Forbes, V. Murugesan, D. Lu, Y. Xia, L. G. Chicoine, N. L. Parinandi, and A. J. Cardounel Role of DDAH-1 in lipid peroxidation product-mediated inhibition of endothelial NO generation Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1679 - C1686. [Abstract] [Full Text] [PDF]